Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 201049

Expand all

PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE (GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE)
2MG;30MG
Marketing Status: Prescription
Active Ingredient: GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE
Proprietary Name: PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2MG;30MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A201049
Product Number: 001
Approval Date: Jan 4, 2013
Applicant Holder Full Name: SANDOZ INC
Marketing Status:  Prescription
Patent and Exclusivity Information
PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE (GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE)
4MG;30MG
Marketing Status: Prescription
Active Ingredient: GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE
Proprietary Name: PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 4MG;30MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A201049
Product Number: 002
Approval Date: Jan 4, 2013
Applicant Holder Full Name: SANDOZ INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English